Profile data is unavailable for this security.
About the company
Regent Pacific Group Ltd, formerly Endurance RP Ltd is an investment holding company principally engaged in biopharma and investment businesses. The Company operates its business through two segments. The Biopharma segment is engaged in the research, development, manufacture, marketing and sale of pharmaceutical products. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The Company is also engaged in aging research and developing artificial intelligence (AI) models and tool products related to aging research. It offers aging and longevity clocks to the longevity clinics, preventative medicine organizations, health clubs, insurance companies, and aging research institutions.
- Revenue in HKD (TTM)7.15m
- Net income in HKD-31.86m
- Incorporated1991
- Employees17.00
- LocationRegent Pacific Group Ltd8FHenley Building 5 Queen's Road Central Hong KongHKG
- Phone+852 25146111
- Fax+852 28104792
- Websitehttps://www.endurancerp.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanai Health Industry Group Co Ltd | 108.27m | -37.61m | 64.98m | 147.00 | -- | 0.1877 | -- | 0.6002 | -0.2459 | -0.1179 | 0.7078 | 2.26 | 0.1994 | 8.97 | 9.71 | 660,201.80 | -7.70 | 3.50 | -10.97 | 5.00 | 17.61 | 37.40 | -38.60 | 10.86 | 2.58 | -6.86 | 0.1487 | 0.00 | -20.92 | 0.8085 | -176.60 | -- | -9.02 | -- |
| Kontafarma China Holdings Ltd | 891.73m | -362.77m | 173.25m | 655.00 | -- | 0.2529 | -- | 0.1943 | -0.065 | -0.065 | 0.1598 | 0.1226 | 0.6269 | 4.43 | 7.06 | 1,296,115.00 | -29.24 | -2.95 | -39.76 | -4.38 | 55.36 | 55.42 | -46.64 | -7.85 | 0.8036 | -- | 0.2753 | -- | 10.93 | -0.5183 | -161.89 | -- | -31.47 | -- |
| PuraPharm Corp Ltd | 346.76m | -38.56m | 176.85m | 469.00 | -- | 1.29 | 12.13 | 0.51 | -0.0976 | -0.0976 | 0.8778 | 0.2568 | 0.4749 | 1.39 | 6.98 | 723,920.70 | -5.28 | -6.50 | -15.35 | -14.97 | 53.93 | 59.22 | -11.12 | -14.08 | 0.3313 | -1.14 | 0.7865 | -- | -6.09 | -11.30 | 66.59 | -- | -29.92 | -- |
| Extrawell Pharmaceutical Holdings Ltd | 52.65m | -337.89m | 201.45m | 161.00 | -- | 0.2257 | -- | 3.83 | -0.1351 | -0.1352 | 0.0219 | 0.3501 | 0.0422 | 10.54 | 5.89 | 322,975.50 | -27.00 | 3.07 | -28.13 | 3.21 | 42.41 | 47.65 | -640.53 | 59.77 | 13.00 | -0.037 | 0.146 | -- | -6.21 | -6.50 | 236.70 | 21.75 | 80.07 | -- |
| Tianda Pharmaceuticals Ltd | 310.50m | -67.37m | 221.45m | 624.00 | -- | 0.4557 | -- | 0.7132 | -0.0313 | -0.0313 | 0.1444 | 0.226 | 0.3931 | 2.84 | 5.14 | 442,937.20 | -8.57 | -- | -12.38 | -- | 42.76 | -- | -21.80 | -- | 0.6900 | -15.81 | 0.2183 | -- | -37.99 | -- | -154.07 | -- | -- | -- |
| Shenzhen Neptunus Intrlng Bi tchnq CoLtd | 1.12bn | 6.98m | 266.80m | 1.47k | 38.19 | 0.3335 | 6.36 | 0.2375 | 0.0042 | 0.0042 | 0.6695 | 0.4768 | 0.783 | 3.68 | 5.65 | 756,546.90 | -0.4295 | 2.52 | -0.6329 | 3.76 | 29.12 | 43.41 | -0.5486 | 3.33 | 1.48 | 2.03 | 0.1157 | 139.17 | -2.18 | -0.7356 | 3.68 | -15.97 | -7.87 | -- |
| Regent Pacific Group Ltd | 7.15m | -31.86m | 294.73m | 17.00 | -- | -- | -- | 41.20 | -0.1388 | -0.1388 | 0.0312 | -0.1117 | 1.20 | -- | 6.96 | 420,776.20 | -535.26 | -47.86 | -- | -61.88 | -- | -- | -445.46 | -1,658.64 | -- | -11.90 | -- | -- | 153.63 | 2.17 | 82.11 | -- | -5.59 | -- |
| Hin Sang Group (Interntnl) Hldng Co Ltd | 95.53m | -40.10m | 316.62m | 185.00 | -- | 2.23 | -- | 3.31 | -0.0367 | -0.0367 | 0.0875 | 0.1299 | 0.1679 | 2.42 | 12.62 | 459,278.80 | -7.03 | -5.77 | -13.64 | -8.41 | 67.28 | 58.19 | -41.89 | -36.55 | 0.0735 | -0.3333 | 0.7032 | -- | -0.7882 | -12.21 | -34.48 | -- | -50.36 | -- |
| Wai Yuen Tong Medicine Holdings Ltd | 721.27m | -13.83m | 416.29m | 726.00 | -- | 0.3519 | 5.63 | 0.5772 | -0.0123 | -0.0123 | 0.6411 | 1.05 | 0.4165 | 1.41 | 9.68 | 950,292.50 | -0.7998 | -1.81 | -1.06 | -3.10 | 49.87 | 44.67 | -1.92 | -11.19 | 0.7806 | -- | 0.2033 | -- | -4.92 | 3.73 | 126.62 | -56.16 | 31.89 | -- |
| China NT Pharma Group Co Ltd | 21.11m | -80.23m | 519.17m | 21.00 | -- | -- | -- | 24.60 | -0.2327 | -0.2327 | 0.0487 | -0.4646 | 0.0546 | -- | 3.09 | 959,413.10 | -20.76 | -10.31 | -- | -- | 51.27 | -- | -380.13 | -97.11 | 0.0447 | -0.3973 | 7.95 | -- | 415.34 | -24.38 | -59.32 | -- | -71.03 | -- |
| Fusen Pharmaceutical Co Ltd | 272.63m | -197.95m | 554.48m | 1.05k | -- | 1.41 | -- | 2.03 | -0.2678 | -0.2678 | 0.3688 | 0.5303 | 0.1875 | 1.11 | 4.05 | 241,048.90 | -13.62 | -2.83 | -32.04 | -5.40 | 41.39 | 51.61 | -72.61 | -8.00 | 0.4241 | -0.4344 | 0.5137 | -- | -42.36 | -4.36 | -420.39 | -- | -17.55 | -- |
Data as of Feb 13 2026. Currency figures normalised to Regent Pacific Group Ltd's reporting currency: Hong Kong Dollar HKD
0.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| British & American Investment Trust Plc (Invt Mgmt)as of 30 Jun 2025 | 21.30k | 0.01% |
Data from 30 Jun 2025 - 30 Jun 2025Source: FactSet Research Systems Inc.
